PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Pharmaron Beijing Co Ltd (3759.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCNE100003PG4
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$35.32B
EPSHK$0.82
PE Ratio9.78
Revenue (TTM)HK$11.54B
Gross Profit (TTM)HK$2.68B
EBITDA (TTM)HK$2.57B
Year RangeHK$8.62 - HK$26.27
Target PriceHK$21.51

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Pharmaron Beijing Co Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Pharmaron Beijing Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2024FebruaryMarchApril
-50.55%
16.40%
3759.HK (Pharmaron Beijing Co Ltd)
Benchmark (^GSPC)

S&P 500

Returns By Period

Pharmaron Beijing Co Ltd had a return of -42.86% year-to-date (YTD) and -63.20% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-42.86%5.29%
1 month-15.67%-2.47%
6 months-50.55%16.40%
1 year-63.20%20.88%
5 years (annualized)N/A11.60%
10 years (annualized)N/A10.43%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-36.03%3.95%-8.94%
20231.86%0.11%1.29%-16.30%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 3759.HK is 8, indicating that it is in the bottom 8% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of 3759.HK is 88
Pharmaron Beijing Co Ltd(3759.HK)
The Sharpe Ratio Rank of 3759.HK is 77Sharpe Ratio Rank
The Sortino Ratio Rank of 3759.HK is 88Sortino Ratio Rank
The Omega Ratio Rank of 3759.HK is 1010Omega Ratio Rank
The Calmar Ratio Rank of 3759.HK is 1212Calmar Ratio Rank
The Martin Ratio Rank of 3759.HK is 55Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Pharmaron Beijing Co Ltd (3759.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


3759.HK
Sharpe ratio
The chart of Sharpe ratio for 3759.HK, currently valued at -0.95, compared to the broader market-2.00-1.000.001.002.003.00-0.95
Sortino ratio
The chart of Sortino ratio for 3759.HK, currently valued at -1.55, compared to the broader market-4.00-2.000.002.004.00-1.55
Omega ratio
The chart of Omega ratio for 3759.HK, currently valued at 0.82, compared to the broader market0.501.001.500.82
Calmar ratio
The chart of Calmar ratio for 3759.HK, currently valued at -0.68, compared to the broader market0.001.002.003.004.005.00-0.68
Martin ratio
The chart of Martin ratio for 3759.HK, currently valued at -1.61, compared to the broader market0.0010.0020.0030.00-1.61
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.79, compared to the broader market-2.00-1.000.001.002.003.001.79
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.61, compared to the broader market-4.00-2.000.002.004.002.61
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.001.002.003.004.005.001.36
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.007.21

Sharpe Ratio

The current Pharmaron Beijing Co Ltd Sharpe ratio is -0.95. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.95
1.77
3759.HK (Pharmaron Beijing Co Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

Pharmaron Beijing Co Ltd granted a 3.63% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.33 per share.


PeriodTTM2023202220212020
DividendHK$0.33HK$0.33HK$0.35HK$0.16HK$0.07

Dividend yield

3.63%2.08%0.98%0.30%0.12%

Monthly Dividends

The table displays the monthly dividend distributions for Pharmaron Beijing Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.33HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.35HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.16HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.07HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%3.6%
Pharmaron Beijing Co Ltd has a dividend yield of 3.63%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%40.2%
Pharmaron Beijing Co Ltd has a payout ratio of 40.19%, which is quite average when compared to the overall market. This suggests that Pharmaron Beijing Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-89.93%
-4.37%
3759.HK (Pharmaron Beijing Co Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Pharmaron Beijing Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Pharmaron Beijing Co Ltd was 90.17%, occurring on Apr 16, 2024. The portfolio has not yet recovered.

The current Pharmaron Beijing Co Ltd drawdown is 89.93%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.17%Jun 29, 2021689Apr 16, 2024
-37.47%Jan 26, 202129Mar 9, 202148May 20, 202177
-28.72%Feb 18, 202025Mar 23, 202020Apr 22, 202045
-23.25%Nov 10, 202015Nov 30, 202015Dec 21, 202030
-14.96%Aug 31, 20209Sep 10, 202020Oct 12, 202029

Volatility

Volatility Chart

The current Pharmaron Beijing Co Ltd volatility is 15.87%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%NovemberDecember2024FebruaryMarchApril
15.87%
3.39%
3759.HK (Pharmaron Beijing Co Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Pharmaron Beijing Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items